Using pharmacological chaperones to restore proteostasis.

Abstract

Normal organismal physiology depends on the maintenance of proteostasis in each cellular compartment to achieve a delicate balance between protein synthesis, folding, trafficking, and degradation while minimizing misfolding and aggregation. Defective proteostasis leads to numerous protein misfolding diseases. Pharmacological chaperones are cell-permeant small molecules that promote the proper folding and trafficking of a protein via direct binding to that protein. They stabilize their target protein in a protein-pharmacological chaperone state, increasing the natively folded protein population that can effectively engage trafficking machinery for transport to the final destination for function. Here, as regards the application of pharmacological chaperones, we focus on their capability to promote the folding and trafficking of lysosomal enzymes, G protein coupled receptors (GPCRs), and ion channels, each of which is presently an important drug target. Pharmacological chaperones hold great promise as potential therapeutics to ameliorate a variety of protein misfolding diseases.

• Authors: Ya-Juan Wang, Xiao-Jing Di, Ting-Wei Mu
• Journal: Pharmacological research (Pharmacol Res) Vol. 83 Pg. 3-9 (May 2014) ISSN: 1096-1186 [Electronic] Netherlands
• PMID: 24747662 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2014 Elsevier Ltd. All rights reserved.

Chemical References

• Ion Channels
• Receptors, G-Protein-Coupled

Topics

• Animals
• Drug Discovery
• Humans
• Ion Channels (chemistry, metabolism)
• Lysosomes (drug effects, enzymology, pathology)
• Protein Folding (drug effects)
• Protein Transport (drug effects)
• Proteostasis Deficiencies (drug therapy, metabolism, pathology)
• Receptors, G-Protein-Coupled (chemistry, metabolism)